09-25-2023, 08:14 PM
"There is no evidence that molnupiravir, sold under the brand name Lagevrio, has produced more transmissible or severe variants of Covid, according to the study."
I wish I had complete confidence in Merck, but I remember what happened with Vioxx. If they had been transparent about its side effects, Vioxx probably could have stayed on the market.
It was the only competitor to Celebrex, and after Vioxx was pulled, Pfizer cancelled a bunch of Celebrex marketing studies that my old employer was scheduled to run. This directly cost me freelance income and did very bad things to the company's financial health. Ripple effect.
I wish I had complete confidence in Merck, but I remember what happened with Vioxx. If they had been transparent about its side effects, Vioxx probably could have stayed on the market.
It was the only competitor to Celebrex, and after Vioxx was pulled, Pfizer cancelled a bunch of Celebrex marketing studies that my old employer was scheduled to run. This directly cost me freelance income and did very bad things to the company's financial health. Ripple effect.